Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02818179

Enrollment

100

Registered

2016-06-29

Start date

2016-12-31

Completion date

2017-07-31

Last updated

2016-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MALIGNANCY

Brief summary

This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness. In addition, normal tissue response to radiation therapy in treated organ will be evaluated.

Interventions

RADIATIONTHERMOGRAPHY IMAGING

Study design

Allocation

Intervention model

SINGLE_GROUP

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* signed informed consent * biopsy proven cervical cancer which will undergo definitive radiation

Exclusion criteria

* not eligible to sign informed consent

Design outcomes

Primary

Measure	Time frame	Description
The change in Infra-Red radiation emitted at wavelengths 0.8-1nm	Baseline and 4 weeks	Measurement of IR

Secondary

Measure	Time frame	Description
Evaluating of efficacy of the radiation	3 months after the treatment	The thermal and the optic imaging will be taken and analyzed in order to evaluate the changing in the temperature of the cervix comparing to the baseline as the indication of the response to the radiotherapy

Contacts

Primary ContactTatiana Rabin, MD

tatiana.rabin@sheba.health.gov.il972-

Backup ContactZvi Symon, MD

zvi.symon@sheba.health.gov.il972

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026